LEADER 00918cam0 2200265 450 001 E600200008393 005 20150605080237.0 100 $a20041230d1983 |||||ita|0103 ba 101 $aeng 102 $aGB 200 1 $aNineteenth-century english literature$fMargaret Stonyk 210 $aLondon$cMacmillan Press$d1983 215 $aXI, 308 p.$cill.$d21 cm 225 2 $aMacmillan history of literature 410 1$1001LAEC00020865$12001 $a*Macmillan history of literature 700 1$aStonyk$b, Margaret$3A600200029612$4070$0251130 801 0$aIT$bUNISOB$c20150605$gRICA 850 $aUNISOB 852 $aUNISOB$j820$m111290 912 $aE600200008393 940 $aM 102 Monografia moderna SBN 941 $aM 957 $a820$b002564$gSi$d111290$rdono Corrado$1pomicino$2UNISOB$3UNISOB$420041230102230.0$520150605080237.0$6Alfano 996 $aNineteenth-century English literature$9100779 997 $aUNISOB LEADER 05385nam 2200685Ia 450 001 9910784536403321 005 20200520144314.0 010 $a1-280-63285-2 010 $a9786610632855 010 $a0-08-045563-8 024 3 $z9780080444741 035 $a(CKB)1000000000365293 035 $a(EBL)269566 035 $a(OCoLC)171134062 035 $a(SSID)ssj0000099221 035 $a(PQKBManifestationID)11132894 035 $a(PQKBTitleCode)TC0000099221 035 $a(PQKBWorkID)10007152 035 $a(PQKB)11477286 035 $a(Au-PeEL)EBL269566 035 $a(CaPaEBR)ebr10137941 035 $a(CaONFJC)MIL63285 035 $a(OCoLC)162567857 035 $a(MiAaPQ)EBC269566 035 $a(PPN)159637279 035 $a(EXLCZ)991000000000365293 100 $a20050302d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAdvances in synthetic organic chemistry and methods reported in US patents$b[electronic resource] /$fThomas F. DeRosa 210 $aAmsterdam ;$aBoston ;$aLondon $cElsevier$d2006 215 $a1 online resource (705 p.) 300 $aDescription based upon print version of record. 311 $a0-08-044474-1 320 $aIncludes bibliographical references and index. 327 $afront cover; copyright; table of contents; front matter; Introduction; body; Acids and Derivatives; Aromatic Carboxylic Acid Derivatives; Azinyloxy,and Phenoxy-Diaryl-Carboxylic Acid Derivatives, Their Preparation and Use as Mixed ETA/ETB Endothelin Receptor Antagonists; Cinnamic Acid Derivatives; Compounds Derived from Benzoic Acid Esters,Composition Containing Said Compounds and Use Thereof; 1,2-Diarylmethylene Derivatives, Their Methods of Preparation, and Their Uses in Therapeutics; Geranic Acid Derivatives 327 $aHalogenated Cinnamic Acids and Esters Thereof, Processes for the Preparation Thereof and Halogenated Aryldiazonium SaltsHalogenation Catalyst; Method for Producing Alkoxy Malonic Acid Dinitriles; Phosphonosuccinic Acid Derivatives, Processes for Their Preparation and Medicaments Containing These Compounds; Preparation of Cyclohexane Carboxylate Derivatives; Water Soluble Fullerenes with Antiviral Activity; Alcohols; Butyne Diol Derivatives; 1,2-Dithin Antiinfective Agents; Oligiocycloalkanoid Compounds and Methods of Use; Polymers with Controlled Physical State and Bioerodibility 327 $a4-Quinolinemethanol Derivatives as Purine Receptor AntagonistsSynthesis of 5-Decenyl Acetate and Other Pheromone Components; Aldols; Stereospecific Synthesis of Aldols; Aldehydes; Process for Selective Catalytic Oxidation of Olefins to Aldehydes, Ketones with Cleavage of C==C Bonds; Alkenes; Carbonyl-Containing Compounds; Alkynes; Diaryl-enynes; DNA-Cleaving Anti-Tumor Agents; Amides; Adamantane Derivatives; o-Anisamide Derivatives; Benzamide Analogues Useful as PARP (ADP-Ribosyltransferase, ADPRT) DNA Repair Enzyme Inhibitors 327 $aCarboxamide Compositions, Methods, and Compositions for Inhibiting PARP ActivityHeterocyclic Amides; Phosphoramide Compounds; Amines; Aminophenyl Ketones Derivatives and a Method for the Preparation Thereof; Arylamine Synthesis; Fungicidal Spirocyclic Amines; Method for Producing Propargylamine Compounds; One Pot Process for the Preparation of 1-[2-Methylamino-(4-Methoxyphenyl)-Ethyl]Cyclohexanol; Organic Electroluminescence Device and Phenylenediamine Derivative; Process for Preparing N-Substituted Hydroxylamines and Salts Thereof; Sodium Channel Modulators 327 $aSubstituted 2-Aminoalkyl 1,4-Diaminobenzene Compounds and Oxidation Dye Precursor Containing the SameAminoacids; Aminoindanes; Aminopropylphosphinic Acids; Cyclic Aminoacids and Derivatives Thereof Useful as Pharmaceutical Agents; Isocyanoalkyl, Carbonic Acid Derivatives, Their Conversion into Secondary Amidoalkyl Carbonic Acid Derivatives by Isocyanide Multicomponent Reactions, as well as these Secondary Amidoalkyl Carbonic Acid Derivatives; Spirodiamino Acid Scaffold for Combinatorial Synthesis; Anthracenones; 10-Substituted 1,8-Dihydroxy-9(10H) Anthracenone Pharmaceuticals 327 $aAza and Diaza Bi-and Tricyclics 330 $a Advances in Synthetic Organic Chemistry and Methods Reported in US Patents provides synthetic guidelines for preparing current and commercially significant organic compounds, derivatives, and intermediates as reported in issued US Patents. Industries surveyed include agrochemical, cosmetics and personal care products. Each entry contains extensive information such as explicit laboratory directions for preparing all chemical intermediates and characterization data. Furthermore, product optimization studies, industrial preparation, and new synthetic methods have been included for select 606 $aOrganic compounds$xSynthesis 606 $aOrganic compounds$xSynthesis$vPatents 606 $aPatents$zUnited States 615 0$aOrganic compounds$xSynthesis. 615 0$aOrganic compounds$xSynthesis 615 0$aPatents 676 $a547.2 700 $aDeRosa$b Thomas F$0863953 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910784536403321 996 $aAdvances in synthetic organic chemistry and methods reported in US patents$93727331 997 $aUNINA LEADER 05804oam 22013814 450 001 9910972474803321 005 20250426110948.0 010 $a9786613829962 010 $a9781462339716 010 $a1462339719 010 $a9781452732992 010 $a145273299X 010 $a9781283517515 010 $a1283517515 010 $a9781451909180 010 $a1451909187 035 $a(CKB)3360000000443922 035 $a(EBL)3014470 035 $a(SSID)ssj0000943301 035 $a(PQKBManifestationID)11523891 035 $a(PQKBTitleCode)TC0000943301 035 $a(PQKBWorkID)10975529 035 $a(PQKB)11310736 035 $a(OCoLC)694141142 035 $a(IMF)WPIEE2006139 035 $a(MiAaPQ)EBC3014470 035 $a(IMF)WPIEA2006139 035 $aWPIEA2006139 035 $a(EXLCZ)993360000000443922 100 $a20020129d2006 uf 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe Credit Risk Transfer Market and Stability Implications for U.K. Financial Institutions /$fLi Ong, Jorge Chan-Lau 205 $a1st ed. 210 1$aWashington, D.C. :$cInternational Monetary Fund,$d2006. 215 $a1 online resource (27 p.) 225 1 $aIMF Working Papers 300 $a"June 2006". 311 08$a9781451863994 311 08$a1451863993 320 $aIncludes bibliographical references. 327 $a""Contents""; ""I. INTRODUCTION""; ""II. CREDIT RISK TRANSFER INSTRUMENTS: STRUCTURED CREDIT PRODUCTS AND CREDIT DERIVATIVES""; ""III. INTERLINKAGES ACROSS FINANCIAL INSTITUTIONS""; ""IV. EXPOSURE OF U. K. FINANCIAL INSTITUTIONS TO CREDIT DERIVATIVES""; ""V. REGULATORY AND SUPERVISORY INITIATIVES""; ""VI. CONCLUSION""; ""HOW COLLATERALIZED DEBT OBLIGATIONS (CDOS) WORK""; ""KEY RISK FACTORS IN CREDIT RISK TRANSFER (CRT) MARKETS""; ""REFERENCES"" 330 3 $aThe increasing ability to trade credit risk in financial markets has facilitated its dispersion across the financial and other sectors. However, specific risks attached to credit risk transfer (CRT) instruments in a market with still-limited liquidity means that its rapid expansion may actually pose problems for financial sector stability in the event of a major negative shock to credit markets. This paper attempts to quantify the exposure of major U.K. financial groups to credit derivatives, by applying a vector autoregression (VAR) model to publicly available market prices. Our results indicate that use of credit derivatives does not pose a substantial threat to financial sector stability in the United Kingdom. Exposures across major financial institutions appear sufficiently diversified to limit the impact of any shock to the market, while major insurance companies are largely exposed to the "safer" senior tranches. 410 0$aIMF Working Papers; Working Paper ;$vNo. 2006/139 606 $aCredit derivatives$zGreat Britain 606 $aDerivative securities$zGreat Britain 606 $aBanking$2imf 606 $aBanks and Banking$2imf 606 $aBanks and banking$2imf 606 $aBanks$2imf 606 $aCapital and Ownership Structure$2imf 606 $aCdos$2imf 606 $aCredit risk$2imf 606 $aCredit$2imf 606 $aDepository Institutions$2imf 606 $aDerivative securities$2imf 606 $aFinance$2imf 606 $aFinancial Instruments$2imf 606 $aFinancial Risk and Risk Management$2imf 606 $aFinancial risk management$2imf 606 $aFinancial services law & regulation$2imf 606 $aFinancing Policy$2imf 606 $aGoodwill$2imf 606 $aIndustries: Financial Services$2imf 606 $aInstitutional Investors$2imf 606 $aInsurance companies$2imf 606 $aInvestments: Derivatives$2imf 606 $aMicro Finance Institutions$2imf 606 $aMonetary economics$2imf 606 $aMonetary Policy, Central Banking, and the Supply of Money and Credit: General$2imf 606 $aMoney and Monetary Policy$2imf 606 $aMortgages$2imf 606 $aNon-bank Financial Institutions$2imf 606 $aPension Funds$2imf 606 $aValue of Firms$2imf 607 $aUnited Kingdom$2imf 615 0$aCredit derivatives 615 0$aDerivative securities 615 7$aBanking 615 7$aBanks and Banking 615 7$aBanks and banking 615 7$aBanks 615 7$aCapital and Ownership Structure 615 7$aCdos 615 7$aCredit risk 615 7$aCredit 615 7$aDepository Institutions 615 7$aDerivative securities 615 7$aFinance 615 7$aFinancial Instruments 615 7$aFinancial Risk and Risk Management 615 7$aFinancial risk management 615 7$aFinancial services law & regulation 615 7$aFinancing Policy 615 7$aGoodwill 615 7$aIndustries: Financial Services 615 7$aInstitutional Investors 615 7$aInsurance companies 615 7$aInvestments: Derivatives 615 7$aMicro Finance Institutions 615 7$aMonetary economics 615 7$aMonetary Policy, Central Banking, and the Supply of Money and Credit: General 615 7$aMoney and Monetary Policy 615 7$aMortgages 615 7$aNon-bank Financial Institutions 615 7$aPension Funds 615 7$aValue of Firms 700 $aOng$b Li$01804802 701 $aChan-Lau$b Jorge$01815656 712 02$aInternational Monetary Fund.$bMonetary and Financial Systems Dept. 801 0$bDcWaIMF 906 $aBOOK 912 $a9910972474803321 996 $aThe Credit Risk Transfer Market and Stability Implications for U.K. Financial Institutions$94371309 997 $aUNINA